辛伐他汀聯(lián)合阿奇霉素治療老年慢性阻塞性肺疾病合并肺動(dòng)脈高壓患者的療效
發(fā)布時(shí)間:2019-05-13 21:04
【摘要】:正慢性阻塞性肺疾病(COPD)是具有氣流受限特征的可防可治的疾病,發(fā)病人群大多數(shù)是老年人,其發(fā)病率和病死率有隨著年齡的增加而增長(zhǎng)的趨勢(shì)~([1-3])。他汀類(lèi)藥物對(duì)Rho A/ROCK信號(hào)通路的激活具有明顯的抑制作用,且存在抗炎和抗氧化的活性,因而可以對(duì)肺動(dòng)脈高壓的發(fā)生、發(fā)展起到阻滯
[Abstract]:Positive and chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with the characteristics of airflow restriction. Most of the patients are elderly. The incidence and mortality of COPD increase with the increase of age ([1 鈮,
本文編號(hào):2476190
[Abstract]:Positive and chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with the characteristics of airflow restriction. Most of the patients are elderly. The incidence and mortality of COPD increase with the increase of age ([1 鈮,
本文編號(hào):2476190
本文鏈接:http://sikaile.net/yixuelunwen/huxijib/2476190.html
最近更新
教材專(zhuān)著